Not checked for notices yet.
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka and 10 more
Arthritis Research & Therapy · 2020
Cited by papers we hold 1
- A Comprehensive Overview of Globally Approved JAK Inhibitors · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.